共 14 条
[1]
[2]
胆汁淤积性肝病临床和基础研究热点和难点[J] 陆伦根; 中华肝脏病杂志 2015, 08
[3]
Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats[J] Markus Slopianka;Anne Herrmann;Mira Pavkovic;Heidrun Ellinger-Ziegelbauer;Rainer Ernst;Angela Mally;Matthias Keck;Bjoern Riefke Toxicology 2017,
[4]
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis[J] Anna Baghdasaryan;Claudia D. Fuchs;Christoph H. Österreicher;Ursula J. Lemberger;Emina Halilbasic;Ingrid Påhlman;Hans Graffner;Elisabeth Krones;Peter Fickert;Annika Wahlström;Marcus Ståhlman;Gustav Paumgartner;Hanns-Ulrich Marschall;Michael Trauner Journal of Hepatology 2016,
[5]
Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype[J] Frédéric M. Vaz;Coen C. Paulusma;Hidde Huidekoper;Minke de Ru;Cynthia Lim;Janet Koster;Kam Ho‐Mok;Albert H. Bootsma;Albert K. Groen;Frank G. Schaap;Ronald P. J. Oude Elferink;Hans R. Waterham;Ronald J.A. Wanders Hepatology 2015,
[6]
ABCG5/ABCG8 in cholesterol excretion and atherosclerosis[J] Xiao-Hua Yu;Kun Qian;Na Jiang;Xi-Long Zheng;Francisco S. Cayabyab;Chao-Ke Tang Clinica Chimica Acta 2014,
[7]
Biosynthesis and trafficking of the bile salt export pump; BSEP: Therapeutic implications of BSEP mutations[J] Carol J. Soroka;James L. Boyer Molecular Aspects of Medicine 2014,
[8]
The SLCO (former SLC21 ) superfamily of transporters[J] Bruno Hagenbuch;Bruno Stieger Molecular Aspects of Medicine 2013,
[9]
Bile acid transporters and regulatory nuclear receptors in the liver and beyond[J] Emina Halilbasic;Thierry Claudel;Michael Trauner Journal of Hepatology 2013,
[10]
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases[J] European Association for the Study of the Liver Journal of Hepatology 2009,

